Overview of the 2022 WHO Classification of Parathyroid Tumors

The 2022 WHO classification reflects increases in the knowledge of the underlying pathogenesis of parathyroid disease. In addition to the classic characteristic features of parathyroid neoplasms, subtleties in histologic features which may indicate an underlying genetic abnormality reflect increased...

Full description

Saved in:

Bibliographic Details
Published in:	Endocrine pathology Vol. 33; no. 1; pp. 64 - 89
Main Authors:	Erickson, Lori A., Mete, Ozgur, Juhlin, C. Christofer, Perren, Aurel, Gill, Anthony J.
Format:	Journal Article
Language:	English
Published:	New York Springer US 01.03.2022 Springer Nature B.V
Subjects:	Adenoma Blood clots Carcinoma Classification Endocrinology Hyperparathyroidism Hyperplasia Immunohistochemistry Medicine Medicine & Public Health Metastases Mitosis Neoplasia Neuroendocrine tumors Nucleoli Oncology Parathyroid Parathyroidectomy Pathogenesis Pathology Patients Renal failure Thrombosis Tumor cells Tumors Parathyroid hyperplasia Inherited hyperparathyroidism Parathyroid adenoma Atypical parathyroid tumor WHO classification Hyperparathyroidism Parathyroid carcinoma Multiglandular parathyroid disease Parafibromin
ISSN:	1046-3976, 1559-0097, 1559-0097
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!